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Abstract
Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), a cattle disease of
global importance. M. bovis infects bovine macrophages (Mø) and subverts the host cell
response to generate a suitable niche for survival and replication. We investigated the role
of the anti-inflammatory cytokine interleukin (IL) 10 during in vitro infection of bovine mono-
cyte-derived Mø (bMDM) with two divergent UK strains of M. bovis, which differentially mod-
ulate expression of IL10. The use of IL10-targeting siRNA revealed that IL10 inhibited the
production of IL1B, IL6, tumour necrosis factor (TNF) and interferon gamma (IFNG) during
infection of bMDM with the M. bovis strain G18. In contrast, IL10 only regulated a subset of
these genes; TNF and IFNG, during infection with the M. bovis reference strain AF2122/97.
Furthermore, nitric oxide (NO) production was modulated by IL10 during AF2122/97 infec-
tion, but not at the nitric oxide synthase 2 (NOS2) mRNA level, as observed during G18
infection. However, IL10 was found to promote survival of both M. bovis strains during early
bMDM infection, but this effect disappeared after 24 h. The role of IL10-induced modulation
of TNF, IFNG and NO production in M. bovis survival was investigated using siRNA target-
ing TNF, IFNG receptor 1 (IFNGR1) and NOS2. Knock-down of these genes individually did
not promote survival of either M. bovis strain and therefore modulation of these genes does
not account for the effect of IL10 on M. bovis survival. However, TNF knock-down was
found to be detrimental to the survival of the M. bovis strain G18 during early infection. The
results provide further evidence for the importance of IL10 during M. bovis infection of Mø.
Furthermore, they highlight M. bovis strain specific differences in the interaction with the
infected bMDM, which may influence the course of infection and progression of bovine TB.
Introduction
Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), which is an
important disease of cattle and other animals around the globe. M. bovis is closely related to
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Mycobacterium tuberculosis, the aetiological agent of human TB. Similar to human disease,
bovine TB results from inhalation of infectious mycobacteria into the lungs, where the patho-
gen is phagocytozed by alveolar macrophages (Mø). Mycobacteria utilize a range of mecha-
nisms to subvert the ability of the host cell to kill the invading pathogen (reviewed by [1]). This
allows mycobacteria to persist within the infected cell, resulting in the formation of granuloma,
aggregates of immune cells that surround and enclose the infected cells, which are indicative
of mycobacteria infection.
Although a test-and-slaughter policy has been in place in the United Kingdom (Great Brit-
ain and Northern Ireland) for over fifty years, the incidence of bovine TB has increased in
recent years, with over 44,000 skin-test positive animals being slaughtered in Great Britain in
2018 [2]. The role of various factors in the increase of bovine TB has been investigated, e.g.
environmental factors, host genetics, farm management practices (reviewed by [3]). In con-
trast, the potential role of the genetics of the pathogen has received less attention. This may be
due to the perceived lack of genetic variation amongst UK M. bovis strains, which exhibit less
genetic diversity than the smaller population of M. bovis in France [4]. However, strains circu-
lating in Northern Ireland exhibit differences in virulence, determined by the proportion of
skin-test positive animals which had visible granulomas [5]. Furthermore, we have shown pre-
viously that two strains of M. bovis isolated in the UK interact in significantly different ways
with bovine monocyte derived Mø (bMDM), a model for alveolar Mø [6], including variation
in intracellular mycobacterial survival and replication, host cell survival and the transcriptional
response of bMDM induced by infection. These differences may alter the formation of granu-
loma, which in turn may impact on disease progression.
The mechanisms behind the dissimilar bMDM response to the two M. bovis strains are
unknown. Infection with one M. bovis strain, AF2122/97 induced a much greater transcrip-
tional response by bMDM, with respect to the number of differentially expressed genes and
the level of differential expression [6]. Only approximately ten percent of genes were affected
to a greater extent by the second M. bovis strain, G18. AF2122/97 also induced more host cell
death and proliferated more rapidly in bMDM than G18. However, from the comparison of
just two strains it is not possible to determine whether the broad variation in the bMDM
response is typical for UK M. bovis strains or if AF2122/97 and G18 are hyper-stimulatory or
hypo-stimulatory, respectively. Furthermore, it is unclear if G18 is actively dampening down
the response of the infected bMDM to promote infection.
One gene that was found to be expressed by bMDM at significantly higher levels during
G18 infection than AF2122/97 infection was interleukin (IL) 10. IL10 is a pleiotropic cytokine
that acts as a master regulator of the immune system, preventing inflammatory pathology by
limiting the immune response. Many pathogens, including viruses, bacteria and protozoa,
have been shown to manipulate IL10 signalling to promote infection (reviewed by [7]). IL10
has previously been shown to promote the intramacrophage survival of several species of
mycobacteria; including M. tuberculosis survival in human Mø [8] and Mycobacterium avium
subspecies paratuberculosis (MAP) [9] and M. bovis survival in bMDM [10]. M. tuberculosis
and MAP induce and enhance the production of IL10 at the transcriptional and post-tran-
scriptional level [11, 12]. Pre-treatment of bMDM with neutralizing anti-IL10 antibody
enhanced the response of bMDM to MAP infection; increasing nitric oxide (NO) production,
phagosome acidification, apoptosis and production of pro-inflammatory cytokines, e.g.
tumour necrosis factor (TNF) (formally known as tumour necrosis factor alpha) and IL12 [9].
Therefore, since the M. bovis strain G18 induced bMDM to produce higher levels of IL10 than
AF2122/97, we hypothesized that IL10 may be involved in dampening down the response of
bMDM to G18 and be more important in promoting G18 intracellular survival than AF2122/
97. We investigated this by attempting to answer a series of questions. Firstly, what is the
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mechanism behind the strain-specific differential expression of IL10? Secondly, is IL10 respon-
sible for dampening down the transcriptional response of bMDM to G18? Thirdly, if IL10 pro-
motes M. bovis infection of bMDM, is it more important for G18 than AF2122/97? To address
these questions, we inhibited IL10 production during M. bovis infection of bMDM using
siRNA. IL10 was found to regulate a subset of the previously identified transcriptional
response of bMDM to infection [6], but this varied with the two strains of M. bovis investi-
gated. Furthermore, although IL10 was differentially expressed by bMDM in response to infec-
tion with the two M. bovis strains, the cytokine promoted the early survival of both strains.
Materials & methods
Animals
Peripheral blood mononuclear cells (PBMC) were isolated from female Holstein-Friesian cat-
tle maintained at The University of Edinburgh Langhill farm, which is free from M. bovis and
MAP. All cattle were less than one year old and were clinically normal. All experimental proto-
cols were authorised under the UK Animals (scientific procedures) Act, 1986 under project
licence number P803DD07A Immunity and Resistance to Disease in Ruminants. In addition,
The Roslin Institute’s Animal Welfare and Ethics Committee (AWEC) ensure compliance
with all relevant legislation and promote the adoption and developments of the 3Rs.
Bacterial strains and culture
bMDM were infected with two strains of M. bovis isolated in the United Kingdom; AF2122/97
(spoligotype SB0140, lineage A) and G18 (spoligotype SB0129, lineage P). The isolates were
cloned prior to growth to mid-log phase (OD600 0.6–0.8) in liquid Middlebrook 7H9 medium
supplemented with 10% albumin-dextrose-catalase (ADC) and 0.1% Tween-80. The mycobac-
teria were then harvested and prepared as single cell cultures before being frozen. The quantity
of M. bovis in the frozen stocks and the proportion of viable mycobacteria were assessed by
quantifying and comparing the number of colony forming units (CFU) and genome copy
number (GCN) in a sample of the frozen vials.
Macrophage culture & challenge
bMDM were generated using a protocol similar to that described previously [13]. In brief,
PBMC were cultured for 2 h in RPMI-1640 medium without serum at 5 x 106 cells/ml, before
the medium was replaced with bMDM medium (RPMI-1640 supplemented with 16.7% FBS,
4mM L-glutamine and 50μM β-mercaptoethanol) with 100U/ml Penicillin-Streptomycin. The
bMDM medium was replaced on day 7. On day 11 the adherent cells were rigorously washed
with phosphate buffered saline (PBS) and detached with TrypLE Express (Thermo Fisher Scien-
tific). Purified bMDM were resuspended at 3 x 105 cells/ml in bMDM medium without Penicil-
lin-Streptomycin, aliquotted into 12 well plates and cultured for 72 h before infection on day 14.
Frozen mycobacteria stocks were thawed and prepared in bMDM medium and inoculated
at a multiplicity of infection (MOI) of 5. Medium only was added to the uninfected controls.
Plates were centrifuged at 300 g for 5 minutes and the medium was replaced 1 h post infection.
Quantification of intracellular M. bovis
The intracellular mycobacterial GCN in each sample was quantified by qPCR as described pre-
viously [6]. Briefly, genomic DNA (gDNA) was isolated from bMDM after infection with M.
bovis for 2, 24 and 48 h using the DNeasy Blood & Tissue kit (Qiagen), following the manufac-
turer’s instructions, including the pre-treatment of samples with lysozyme to maximise
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recovery of mycobacterial DNA. The abundance of mycobacterial genome copies in each sam-
ple was quantified by qPCR by amplification of the M. bovis 85B antigen gene (MY85B) as
described previously [6].
Intracellular mycobacteria were also quantified as CFU. Infected bMDM were lysed 2, 24
and 48 h post infection (hpi) with 0.5 ml PBS + 0.1% Triton-X-100 and incubated at room
temperature for 10 minutes. Aliquots of a 10 fold dilution series were plated onto Middlebrook
7H11 agar plates supplemented with 10% oleic-albumin-dextrose-catalase (OADC) and incu-
bated at 37˚C until colonies could be accurately counted.
Knock-down of target genes by siRNA
bMDM were harvested on day 9, resuspended at 3 x 105 cells/ml in bMDM medium, dispensed
into 12 well plates and cultured for 72 h before transfection of siRNA. siRNA duplexes were
designed and supplied by Sigma-Aldrich (Table 1). The bMDM were transfected using Lipo-
fectamine RNAiMAX (Thermo Fisher Scientific) as described previously [14]. The MIS-
SION1 siRNA Universal Negative Control #1 siRNA (Sigma-Aldrich), which does not share
homology with any known mammalian gene, was used as a non-target siRNA control (NTC
siRNA). After 24 h the medium was replaced with fresh medium to remove the residual
siRNA/Lipofectamine RNAiMAX mix. After a further 24 h (day 14) cells were infected with
M. bovis strains as described above or stimulated with 100 ng/ml phenol-extracted lipopolysac-
charide (LPS) derived from Escherichia coli 055:B5 (Sigma-Aldrich) with or without the addi-
tion of 500 pg/ml recombinant bovine IFNG (Bio-Rad).
Effect of exogenous IFNG
bMDM were infected with M. bovis as described above. After 1 h the medium was removed
and replaced with bMDM medium containing different concentrations of recombinant bovine
IFNG (Bio-Rad).
Quantitative RT-PCR (RT-qPCR) analysis
RNA was extracted from bMDM using the ReliaPrep RNA cell miniprep kit (Promega) with
an on-column DNAse step as directed by the manufacturers. RNA was quantified using the
NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). First strand cDNA was
reverse transcribed from 200–500 ng total RNA using oligo(dT) primer and GoScript reverse
transcriptase (Promega) according to the manufacturer’s instructions. The resulting cDNA
was diluted 1:20 for all genes. Oligonucleotides were designed for each gene using Primer3
[15, 16] and Netprimer (Biosoft International) software (Table 2). The qPCR reaction was car-
ried out as described previously [6]. The relative quantities of mRNA were calculated using the
method described by Pfaffl (2001) [17], using the RT-qPCR results for RALBP1 associated Eps
domain containing 1 (REPS1) to calculate differences in the template RNA levels and thereby
standardize the results for the genes of interest.
Table 1. Details of the siRNA used in this study.
Gene Accession
No.
Target sequence (5’-3’)
interferon gamma receptor 1 (IFNGR1) NM_001035063 GAAAGTTGGACCACCTAAA
interleukin 10 (IL10) NM_174088 CATAGAAACCTACATGACA
nitric oxide synthase 2 (NOS2/iNOS) NM_001076799 GCTATTGGGTCAAGGATAA
tumour necrosis factor (TNF) NM_173966 CACTCAGGTCCTCTTCTCA
https://doi.org/10.1371/journal.pone.0222437.t001
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Enzyme-linked immunosorbent assays (ELISA)
IL10, IL1B and IFNG protein levels were quantified in supernatants collected from bMDM.
IL10 protein was quantified by ELISA using the mouse anti-bovine IL10 antibodies MCA2110
and MCA211b (Bio-Rad) as coating and detecting antibodies respectively. Both antibodies
were used at 2 μg/ml final concentration. The concentration of IL10 was determined using a
standard curve of recombinant ovine IL10 (kindly provided by Dr. Jayne Hope, The Roslin
Institute). IL1B and IFNG protein levels in the supernatants were quantified using the Bovine
IL1β Screening Kit (Thermo Scientific Pierce) and bovine IFNG specific ELISA Assay kit (Bio-
Rad), respectively, following the manufacturers’ instructions. All ELISAs were carried out
using Nunc-Immuno Maxisorp 96 well plates, with all samples and standards in triplicate. The
plates were read at 450 nm, with the reference values at a wavelength of 550 nm subtracted,
using a Cytation 3 plate reader (BioTek).
Griess assay
The production of nitric oxide (NO) by bMDM infected with M. bovis was quantified by mea-
suring nitrite in the supernatants using the Griess Reagent System (Promega) following the
manufacturer’s instructions. Absorbance was measured at 540 nm using a Cytation 3 plate
reader (BioTek).
Statistical analysis
All statistical analysis was carried out using Minitab version 17. The data were transformed on
the log10 scale before statistical analyses to stabilize the variance. Changes in gene expression
in response to the two different M. bovis strains were analysed by t-test. Comparisons between
bMDM treated with different siRNA were analysed by General Linear Model (GLM), fitting
biological replicate as a random effect, with time (where applicable) and siRNA as fixed effects.
Subsequent Fisher’s tests were used to identify significant differences between siRNA treat-
ments, as well as the interaction between siRNA and time.
Table 2. Details of the RT-qPCR oligonucleotides used in the study.
Gene Accession
No.
Orientation Primer sequence (5’-3’)
interferon gamma (IFNG) NM_174086 F
R
GCAAGTCTATGGGATTTCAAGG
GGCATCATTTCATTTATCAGCA
interferon gamma receptor 1 (IFNGR1) NM_001035063 F
R
CTTCTCTTTCTTGTATTTGCTCTGG
ACTTGGTGCCTTCTCGCTTA
interleukin 1, beta (IL1B) NM_174093 F
R
TCCGACGAGTTTCTGTGTGA
TGTGAGAGGAGGTGGAGAGC
interleukin 6 (IL6) NM_173923 F
R
ACCACTCCAGCCACAAACAC
ATGCCCAGGAACTACCACAA
interleukin 10 (IL10) NM_174088 F
R
TGGATGACTTTAAGGGTTAC
AGGGCAGAAAGCGATGAC
nitric oxide synthase 2 (NOS2/iNOS) NM_001076799 F
R
GAGGAGATGCTGGAGATGGC
TGAACATAGACCTTGGGCTGG
tumour necrosis factor (TNF) NM_173966 F
R
GGGACACCCAGAATGTGAG
ATTGGCAGGAAGGGAGAGTT
RALBP1 associated Eps domain
containing 1 (REPS1)
NM_001193011 F
R
AAGCCGAGAAACATCCAGAG
ACATTGGCGGGAGCACTA
F and R denote forward and reverse primers respectively
https://doi.org/10.1371/journal.pone.0222437.t002
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Results
Differential expression of IL10 by bMDM infected with different M. bovis
strains
Previously we have shown that significantly more IL10 mRNA was produced by bMDM at
24–72 hpi in response to infection with G18 than AF2122/97 [6]. To confirm this result the
expression of IL10 was investigated in bMDM derived from a different cohort of animals. No
significant difference in IL10 mRNA produced in response to bMDM infection with the two
M. bovis strains was observed 2 hpi (Fig 1A). By 6 hpi IL10 transcription had decreased, but
significantly more IL10 mRNA was detected in bMDM infected with AF2122/97 than G18,
with on average 1.5 times more IL10 mRNA detected in AF2122/97 infected bMDM (p =
0.039), which was not observed in our previous study [6]. However, at 48 hpi the pattern of
IL10 expression was reversed, with significantly more IL10 mRNA being produced by bMDM
infected with G18 than AF2122/97. On average 2.2 times more IL10 mRNA was detected 48
hpi in bMDM infected with G18 than those infected with AF2122/97 (p = 0.008) (Fig 1A).
Fig 1. IL10 is differentially expressed by bMDM in response to infection with the two M. bovis strains and is regulated by IFNG. A) Summary of the RT-qPCR
analysis of the average IL10 mRNA fold change during the infection of bMDM with M. bovis strains AF2122/97 (green bars) and G18 (blue bars) compared to
uninfected controls. Error bars denote the standard error of seven biological replicates and the statistical significance is indicated on the figure, where n.s. denotes no
significant difference. B & C) Graphs summarising the average IL10 protein production by bMDM infected with M. bovis strain AF2122/97 (B) and G18 (C) in the
presence of different concentrations of exogenous recombinant bovine IFNG. BU denotes Biological Units. ■ denotes no exogenous IFNG, ◆ denotes 50 pg/ml IFNG, ▲
represents 500 pg/ml IFNG and ● denotes 5,000 pg/ml IFNG. Error bars denote the standard error of seven biological replicates.
https://doi.org/10.1371/journal.pone.0222437.g001
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PLOS ONE | https://doi.org/10.1371/journal.pone.0222437 September 17, 2019 6 / 18
Investigation of the mechanism underlying the M. bovis strain-specific
differential expression of IL10 by bMDM
IL10 production is modulated by several mechanisms and we were interested to know what
mechanism regulates the strain specific differential expression of IL10 during M. bovis infec-
tion. Production of IL10 is known to be inhibited by IFNG [18] and we have previously shown
that IFNG is produced by bMDM infected with M. bovis and that significantly more was pro-
duced in response to AF2122/97 than G18 [6]. The differential production of IFNG by bMDM
coincided with the divergence in IL10 mRNA transcription, with nearly twice as much IFNG
protein being detected in supernatants 24 hpi from bMDM infected with AF2122/97 than
from those infected with G18 [6]. Therefore, we postulated that IFNG was inhibiting IL10 pro-
duction by AF2122/97 infected bMDM. To investigate this, we quantified IL10 protein pro-
duction by bMDM during M. bovis infection in the presence of different concentrations of
recombinant IFNG, which were added 1 hpi to prevent priming of bMDM. The results for
AF2122/97 and G18 infected bMDM are summarised in Fig 1B and 1C, respectively. Due to
the greater transcription of IL10 early in infection (Fig 1A), the amount of IL10 protein
detected in supernatants was higher in response to infection with AF2122/97 than G18. How-
ever, the addition of exogenous IFNG significantly inhibited the production of IL10 protein in
response to infection with both M. bovis strains. Average IL10 protein levels detected 24 h after
AF2122/97 infection were reduced from 3.3 Biological Units (BU)/ml by untreated bMDM to
2.6 BU/ml (p = 0.026), 1.9 BU/ml (p< 0.001) and 1.5 BU/ml (p< 0.001) by bMDM treated
with 50 pg/ml, 500 pg/ml and 5,000 pg/ml IFNG, respectively (Fig 1B). Similar results were
observed during G18 infection. Although the reduction in IL10 protein from on average 2.1
BU/ml by untreated bMDM to 1.7 BU/ml in the presence of 50 pg/ml IFNG was not statisti-
cally significant (p = 0.238), there was a significant reduction in IL10 protein levels when
bMDM were treated with 500 pg/ml and 5,000 pg/ml IFNG, with on average 1.4 BU/ml
(p = 0.008) and 1.2 BU/ml (p = 0.002) IL10, respectively. These results support the hypothesis
that differential expression of IFNG could regulate the M. bovis strain-specific differential
expression of IL10.
Investigating the importance of IL10 in determining the transcriptional
response of bMDM to different M. bovis strains
Infection with the two M. bovis strains included in this study have previously been shown to
induce a significantly different transcriptional response by bMDM [6]. The response to
AF2122/97 was much greater, with respect to the number of differentially expressed genes and
the degree of differential expression [6]. However, it was unclear if this variation was due to
AF2122/97 inducing a hyper-response or G18 dampening down the response.
We hypothesized that the greater expression of IL10 in response to G18 infection may be a
mechanism by which G18 silences the bMDM response to infection. To study this we investi-
gated the effect of knocking-down the expression of IL10 by siRNA. There was no significant
difference in cell viability of bMDM transfected with NTC siRNA or IL10 siRNA (S1 File).
However, approximately 75% less IL10 protein was detected in supernatants from bMDM
treated with IL10 siRNA compared to those treated with NTC siRNA (Fig 2). The IL10 protein
levels were reduced to a level similar to that observed in supernatants from uninfected bMDM.
There was no significant difference in the IL10 protein detected in the supernatants induced
by the two M. bovis strains, which differs from earlier results (Fig 1B and 1C), but has been
observed before [6] and relates to the accumulation of protein in the supernatants produced
early in infection before the transcription of IL10 induced by the two M. bovis strains diverges.
Interleukin-10 & Mycobacterium bovis
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The effect of IL10 knock-down on the expression of a subset of pro-inflammatory cyto-
kines; IL1B, IL6, TNF and IFNG, was quantified. All four investigated genes exhibited M.
bovis-strain specific differential expression. On average 5.6 times more IL1B mRNA (p<
0.001), 5.2 times more IL6 mRNA (p< 0.001), 4.3 times more TNF mRNA (p< 0.001) and
48.5 times more IFNG mRNA (p< 0.001) were produced by bMDM pre-treated with NTC
siRNA in response to AF2122/97 infection than G18 infection (Fig 3). The mRNA levels of all
four genes were significantly higher 24 hpi in G18 infected bMDM in the absence of IL10 com-
pared to NTC siRNA treated controls (Fig 3A–3D). For example, IFNG mRNA levels were on
average 5.5 times higher in response to G18 infection when IL10 was knocked-down. IL10
knock-down resulted in the production of IL1B and IL6 mRNA levels similar to that produced
by AF2122/97 infected bMDM treated with NTC siRNA (Fig 3A and 3C). However, levels of
TNF and IFNG were still significantly lower than observed in AF2122/97-infected bMDM (Fig
3B and 3D). In contrast to the effect of IL10 knock-down during G18 infection of bMDM,
IL1B and IL6 mRNA levels were not significantly affected by IL10 knock-down during
AF2122/97 infection (Fig 3A and 3C). However, IFNG and TNF expression were significantly
affected by the presence of IL10, with on average 2.7 and 1.7 times more IFNG and TNF
mRNA, respectively, detected in bMDM pre-treated with IL10 siRNA compared to NTC
siRNA (Fig 3B and 3D).
Fig 2. Successful knock-down of IL10 with siRNA. Graph illustrating successful knock-down by siRNA of IL10 protein production during infection with M.
bovis strains AF2122/97 (green lines) and G18 (blue lines). Solid lines denote bMDM treated with NTC siRNA and dotted lines denote bMDM treated with
IL10 siRNA 48 h prior to infection. The grey line represents IL10 production by uninfected bMDM. Error bars denote the standard error of seven biological
replicates.
https://doi.org/10.1371/journal.pone.0222437.g002
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Fig 3. IL10 knock-down has variable effects on the cytokine response of bMDM to infection with M. bovis strains. Average A) IL1B, B) TNF, C) IL6 and D) IFNG
mRNA fold change 24 hpi compared to uninfected controls. Average E) IL1B protein and F) IFNG protein detected in supernatants 48 hpi and 24 hpi, respectively.
bMDM were infected with M. bovis strains AF2122/97 (green bars) or G18 (blue bars) 48 h after transfection with NTC siRNA (solid bars) or IL10 siRNA (dotted
bars). Error bars denote the standard error of nine biological replicates. The average fold difference (IL10 siRNA compared to NTC siRNA) and the p value of the
statistical analysis are indicated on the bars.
https://doi.org/10.1371/journal.pone.0222437.g003
Interleukin-10 & Mycobacterium bovis
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To confirm the biological effect of IL10 on the expression of other cytokines, the production
of IL1B and IFNG protein was quantified by ELISA (Fig 3E and 3F). Previously we have
shown that M. bovis infection results in the release of pro-IL1B and the active form, which are
both detected in the ELISA [6]. In agreement with the RT-qPCR analysis (Fig 3A) the amount
of IL1B protein secreted by G18 infected bMDM were significantly higher when IL10 was
reduced, with on average 4.9 times more IL1B being detected in the supernatants (Fig 3E).
However, the production of IL1B was not affected by IL10 knock-down during AF2122/97
infection at the mRNA or protein level (Fig 3E). In contrast, IFNG produced by bMDM in
response to AF2122/97 and G18 infection increased when IL10 was knocked-down (Fig 3F).
On average 2.1 and 3.2 times more IFNG were produced by bMDM treated with IL10 siRNA
rather than NTC siRNA during AF2122/97 and G18 infection, respectively.
The results reveal that IL10 has variable effects during infection of bMDM with different M.
bovis strains. During G18 infection the expression of all investigated proinflammatory cyto-
kines was modulated by IL10. The action of IL10 appears to be solely responsible for the sup-
pression of IL1B and IL6 production during G18 infection, thus supporting our hypothesis
that IL10 induced during G18 infection is dampening down some of the transcriptional
response of bMDM to infection. However, other aspects of the strain-specific differential tran-
scriptional response of bMDM are being regulated by additional, currently unidentified,
mechanisms.
The effect of IL10 on the production of nitric oxide (NO) was also investigated by quantify-
ing the amount of the breakdown product nitrite (NO2
-) in the supernatants. Significantly
more NO2
- was detected in response to AF2122/97 than G18 infection (p = 0.026). In addition,
the amount of NO2
- was significantly higher in bMDM treated with IL10 siRNA, with on aver-
age 1.6 and 1.8 times more NO2
- produced by AF2122/97 and G18 infected bMDM, respec-
tively (Fig 4A). The production of NO during Mø activation is mainly regulated by modifying
transcription of nitric oxide synthase 2 (NOS2/iNOS) (reviewed by [19]). To investigate if NO
production was being regulated at the transcriptional level, the amount of NOS2 mRNA was
quantified. As with the investigated pro-inflammatory cytokines, NOS2 mRNA levels were sig-
nificantly higher, with on average 2.7 times more NOS2 mRNA (p< 0.001) being detected,
during G18 infection in the absence of IL10 (Fig 4B). However, NOS2 mRNA levels were not
significantly affected during AF2122/97 infection by the absence of IL10. Therefore, IL10
Fig 4. IL10 regulates nitric oxide production during M. bovis infection. A) Average nitrite levels in supernatants 48 hpi and B) average NOS2 mRNA fold change 24
hpi for bMDM infected with M. bovis strains AF2122/97 (green bars) or G18 (blue bars). bMDM were treated with NTC siRNA (solid bars) or IL10 siRNA (dotted bars)
48 h prior to infection. Error bars denote the standard error of nine biological replicates. The average fold difference (IL10 siRNA compared to NTC siRNA) and the p
value of the statistical analysis are indicated on the bars.
https://doi.org/10.1371/journal.pone.0222437.g004
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appears to regulate NO production by different mechanisms during AF2122/97 and G18
infections.
Effect of IL10 on M. bovis intracellular survival
The results described above suggest that the suppression of IL10 has a greater effect on the
bMDM response to G18 infection than AF2122/97 infection, supporting the hypothesis that
IL10 is more important for promoting infection of G18 than AF2122/97. Therefore, the effect
of IL10 on the survival and/or replication of intracellular M. bovis was investigated. Intracellu-
lar mycobacteria numbers were quantified by two methods; GCN, which detects live and non-
viable mycobacteria, and CFU, which quantifies viable mycobacteria. Knocking-down IL10
had no effect on mycobacterial uptake by bMDM and, as observed previously [6], similar
numbers of intracellular G18 and AF2122/97 were detected 2 hpi by GCN (Fig 5A) and CFU
(Fig 5B). However, thereafter the growth of the two M. bovis strains differed significantly, as
observed previously [6], with much greater growth of AF2122/97, especially during the first 24
h. In contrast, numbers of G18 measured by CFU dropped during the first 24 h (Fig 5B),
although the GCN quantification illustrates that replication was occurring at a low level during
this time (Fig 5A). The mechanism behind this profound difference in early intracellular sur-
vival is currently unknown, but presumably is due to genetic differences between the M. bovis
strains, which may affect how they modulate the microenvironment of the phagosome they
dwell in.
In disagreement with our hypothesis, the loss of IL10 only caused a significant difference in
the GCN of AF2122/97 at 48 hpi (Fig 5A), with on average 19% less M. bovis genomes being
detected in IL10 siRNA treated bMDM (p = 0.019). However, a significant reduction in CFU
numbers was detected for both AF2122/97 and G18 at 24 hpi (Fig 5B), with on average a 32%
(p = 0.013) and 21% (p = 0.044) reduction in intracellular AF2122/97 and G18, respectively.
This suggests that even though IL10 knock-down had a greater effect on the bMDM response
to G18 infection, IL10 is important for the survival of both M. bovis strains during bMDM
infection. In fact, the effect of IL10 knock-down appears to be more transient in G18 infection,
as no effect on bacteria numbers was observed at 48 hpi.
Fig 5. IL10 promotes survival of M. bovis during bMDM infection. Graphs summarising the average number of intracellular M. bovis AF2122/97 (green lines) and
G18 (blue lines) during bMDM infection quantified by A) GCN and B) CFU counts. bMDM were treated 48 h prior to infection with NTC siRNA (solid lines) or IL10
siRNA (dotted lines). Error bars denote the standard error of seven biological replicates. � denotes that the siRNA had a statistically significant effect on intracellular M.
bovis numbers by GLM and subsequent Fisher’s test (p< 0.05).
https://doi.org/10.1371/journal.pone.0222437.g005
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Investigation of the mechanism(s) behind the IL10 effect on M. bovis
survival/growth in bMDM
Reducing IL10 expression in bMDM during M. bovis infection affected the survival and/or
replication of both AF2122/97 and G18. We predicted that the mechanism behind this effect
of IL10 is likely to be conserved between M. bovis strains. Our investigations on the transcrip-
tional response of bMDM found that the production of TNF and IFNG in response to infec-
tion with both M. bovis strains was affected by removing IL10. Furthermore, the NO response
was also affected with both strains, although possibly by different mechanisms. Therefore, we
wished to investigate if these three down-stream effects of IL10 were responsible for IL10 pro-
moting M. bovis infection. This was addressed using siRNA targeting TNF, NOS2 and inter-
feron gamma receptor 1 (IFNGR1/IFNGRα). The TNF and NOS2 mRNA levels were reduced
by approximately 70% and 77%, respectively, with the relevant target siRNA (Fig 6A and 6B).
Unfortunately, attempts to directly knock-down IFNG mRNA levels failed and therefore we
targeted a component of the IFNG receptor, IFNGR1. This resulted in an approximately 68%
Fig 6. Regulation of TNF, IFNG and NO production do not individually account for the effect of IL10 on intracellular M. bovis survival. Graphs confirming A)
TNF, B) NOS2 and C) IFNGR1 gene knock-down 24 h post LPS activation of bMDM pre-treated with NTC siRNA or siRNA targeting TNF, NOS2 and IFNGR1
quantified by RT-qPCR. The results are expressed as the percentage mRNA compared to the NTC siRNA sample. Error bars denote the standard error of five biological
replicates. D) Confirmation that IFNGR1 knock-down inhibits IFNG signalling by illustrating the production of IL1B by bMDM pre-treated with NTC siRNA (solid
bars) or IFNGR1 siRNA (striped bars) 24 h post activation with LPS with/without recombinant IFNG. Error bars denote the standard deviation of two biological
replicates. E) Graph summarizing the effect of target gene knock-down on NO production quantified by measuring the nitrite concentration in the supernatants 48 hpi
with M. bovis strain AF2122/97. Error bars denote the standard error of five biological replicates. F) Graph summarizing the average number of intracellular M. bovis
AF2122/97 (green bars) and G18 (blue bars) quantified by GCN at 24 hpi. bMDM were treated 48 h prior to infection with NTC siRNA (solid bars) or siRNA targeting
TNF (diagonal striped bars), NOS2 (checker-board bars) and IFNGR1 (horizontal striped bars). Error bars denote the standard error of five biological replicates. �
denotes p< 0.05, �� denotes p< 0.005 and ��� denotes p< 0.001 statistically significant effect of siRNA compared to NTC siRNA by GLM and subsequent Fisher’s test.
https://doi.org/10.1371/journal.pone.0222437.g006
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reduction in IFNGR1 mRNA levels (Fig 6C), which reduced IFNG signalling by approximately
two-thirds (Fig 6D). Knocking-down NOS2 reduced the nitrite levels in the supernatants 48
hpi by 93% with AF2122/97 infection (Fig 6E). Knocking-down TNF also significantly reduced
NO production by 73% (Fig 6E), by indirectly reducing NOS2 mRNA levels (Fig 6B), illustrat-
ing the complexity of the bMDM response to M. bovis infection.
Pre-treatment with the different siRNA had no effect on M. bovis GCN 2 hpi (S1 Fig). Fur-
thermore, knock-down of these three target genes individually had no significant effect on the
survival and/or growth of AF2122/97 at 24 hpi or 48 hpi, quantified by GCN (p> 0.05) (Fig 6F
and S1 Fig). However, it should be noted that in four out of the five biological replicates knock-
ing-down TNF and NOS2 resulted in higher AF2122/97 GCN 24 hpi. Therefore, host genetics
may play a role in the importance of these genes during infection. Reducing TNF production
had a significant effect on intracellular G18 survival in bMDM (Fig 6F). Unexpectedly, knock-
ing-down TNF was detrimental to G18 survival in bMDM, with a 16% reduction in intracellu-
lar G18 at 24 hpi (p = 0.003) (Fig 6D). However, this effect was lost by 48 hpi. NOS2 and
IFNGR1 knock-down had no significant effect on G18 GCN at 24 hpi (Fig 6F) or 48 hpi (S1
Fig). Overall, the results suggest that alternative mechanisms are involved in IL10 promoting
M. bovis infection of bMDM.
Discussion
IL10 is an important regulator of the immune response, dampening down its activity to limit
immune-associated pathology. A range of pathogens have evolved different ways to manipu-
late IL10 signalling to promote their survival (reviewed by [7, 20]). Pathogenic mycobacteria
species use several mechanisms to augment IL10 production. M. tuberculosis and MAP modu-
late the balance of histone deacetylases that alter the chromatin conformation at the IL10 pro-
moter, thus allowing greater access by transcription factors [12, 21]. Furthermore, MAP
down-regulates production by murine Mø of a miRNA, miRNA-27a-3p, that indirectly inhib-
its IL10 [11]. The fact that mycobacteria use multiple mechanisms to enhance IL10 production
supports the hypothesis that this cytokine plays an important role in the interaction between
host Mø and pathogens. This has been confirmed by several studies investigating the effect of
reducing IL10 expression during infection with MAP [9], M. bovis [10] and M. tuberculosis
[8].
Our interest in IL10 arose from the discovery that two strains of M. bovis induced differen-
tial expression of IL10 by bMDM, which correlated with the intensity of the bMDM response
to infection. The M. bovis strain G18, which induced prolonged expression of IL10, elicited a
more silent and less cytotoxic infection than the M. bovis strain AF2122/97 [6]. We wished to
investigate if IL10 was involved in dampening down the response of bMDM to G18. Firstly,
we investigated the cause of the differential expression of IL10. As a master regulator of the
immune response, IL10 production is regulated at multiple stages, including chromatin
remodelling and post-transcriptional regulation (reviewed by [18, 22]). We identified IFNG as
an inhibitor of IL10 production during M. bovis infection of bMDM. IFNG inhibits MAP
kinases and regulates GSK3 to suppress the transcription factors CREB and AP-1, which posi-
tively regulate IL10 expression in human Mø [23]. Further work is required to investigate if
this is the mechanism involved in IFNG suppression of IL10 production during M. bovis
infection.
Reducing IL10 production by bMDM with siRNA reduced intracellular M. bovis numbers
by over twenty percent at 24 hpi measured by CFU. CFU quantifies live M. bovis and no signif-
icant difference was observed by quantifying GCN at this time point, which quantifies live and
inactive M. bovis. Therefore, M. bovis replication was occurring, but more mycobacteria were
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being killed in the absence of IL10. The use of IL10 siRNA revealed that bMDM-derived IL10
was of similar importance for the survival of G18 and AF2122/97, in contrast to what we had
hypothesized. There was no significant difference in the percentage reduction in G18 and
AF2122/97 CFU quantified 24 hpi. Furthermore, no IL10 associated difference in M. bovis
CFU was observed 48 hpi, although there was a reduction in AF2122/97 GCN at this time
point. Therefore, the effect of IL10 was transient and was overcome by G18 and, to a lesser
extent, AF2122/97. This suggests that the early production of IL10, when there was no signifi-
cant difference in the amount produced by bMDM in response to AF2122/97 and G18 [6], is
most important for M. bovis survival, not IL10 production after 24 h when the strain-specific
differential expression of IL10 was observed. The biological relevance of this transient effect of
IL10 on intracellular M. bovis is unclear and could only be resolved in the context of in vivo
infections involving the entire immune system. The transient effect of IL10 on M. bovis intra-
cellular growth described here differs from a previous study which found that the addition of
anti-IL10 antibody resulted in a significant reduction in M. bovis replication five days post
infection [10]. This discrepancy may relate to differences in the experimental design of the two
studies. The earlier study used bMDM primed with LPS and IFNG before infection, used a
lower MOI and reduced IL10 levels using a neutralizing antibody.
AF2122/97 infection of bMDM induces a much greater transcriptional response than G18,
including a multitude of pro-inflammatory mediators, e.g. cytokines. The role of IL10 in regu-
lating the transcriptional response of bMDM to the two M. bovis strains was therefore investi-
gated. Blocking IL10 has been shown to increase TNF, IL12 and IL8 production by bMDM [9]
and enhance IFNG production by bovine PBMC [24] infected with MAP. Similarly, treatment
of bMDM with IL10 siRNA enhanced expression of IL1B, TNF, IL6, IFNG and NOS2 induced
by G18 infection. Therefore, IL10 is involved in regulating the transcriptional response of
bMDM to M. bovis infection. However, this effect was strain specific, with only TNF and
IFNG mRNA levels being augmented by IL10 siRNA during AF2122/97 infection. This high-
lights the importance of confirming observations with more than one M. bovis strain.
Although AF2122/97 is widely considered as a UK reference strain of M. bovis and frequently
used in experimental infection studies [25, 26], it appears to differ significantly from G18 and
therefore may not be representative of the M. bovis strains currently circulating in the UK and
globally.
IL1B and IL6 expression by AF2122/97 infected bMDM was not affected by blocking IL10
production. Interestingly, blocking IL10 during G18 infection resulted in elevated expression
of these two cytokines to similar levels measured during AF2122/97 infection. Therefore, the
M. bovis induced production of IL10 is solely responsible for the strain-specific differential
expression of these genes. However, although IL10 siRNA resulted in elevated TNF and IFNG
mRNA levels during G18 infection, they remained significantly lower than that measured dur-
ing AF2122/97 infection. Therefore, other, currently unknown, factors are co-regulating the
expression of these genes.
The work described here shows that IL10 is involved in the regulation of NO production by
bMDM during M. bovis infection. However, the mechanism involved may differ with different
M. bovis strains. Levels of the NO breakdown product nitrite in the supernatants were signifi-
cantly higher when IL10 was knocked-down during bMDM infection with both M. bovis
strains. Regulation of NOS2 expression is the principal mechanism controlling NO production
in immune cells (reviewed by [19]). However, NOS2 mRNA levels were only affected by IL10
siRNA during G18 infection. Therefore, NO production in AF2122/97 infected bMDM must
be regulated by another mechanism. Two other genes encode NO synthases that can synthe-
size NO; NOS1 and NOS3. These are expressed at extremely low levels in bMDM and mRNA
levels were not affected by M. bovis infection [6]. This suggests that NOS2 is being regulated at
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the post-translational or enzymatic level during AF2122/97 infection. The availability of argi-
nine, the precursor of NO, is the rate-limiting step for NOS2 activity and can be modulated by
changes in arginine transport or competition with other biochemical pathways. In particular,
arginases can down-regulate NO production by competing with NOS2 for arginine (reviewed
by [27]). Interestingly, arginase 2 is up-regulated in bMDM to a greater extent and for a longer
duration during infection with AF2122/97 than G18 [6]. Further work is required to ascertain
the mechanism behind the regulation of NO production by IL10 during AF2122/97 infection.
In this study we investigated if the regulation of TNF, IFNG and NO by IL10 was important
in promoting M. bovis survival. Previous work supports this theory, for example NOS2 defi-
cient mice are highly susceptible to M. tuberculosis infection [28]. However, the importance of
NO during M. bovis infection is less clear. Treatment of bMDM with the NO inhibitor nG-
monomethyl-L-arginine monoacetate (MMLA) enhanced intracellular growth of M. bovis in
one study [29], whilst MMLA had no effect in an earlier study [10], in agreement with our
results. The disparity may be due to the different strains of M. bovis investigated in these stud-
ies, significantly less NO was generated by bMDM in response to G18 than AF2122/97. The
importance of TNF during mycobacterial infections has been illustrated in mouse studies. It
plays a pivotal role in the maintenance of the structure and function of the granuloma, but also
acts by inducing the anti-mycobacterial activity of murine Mø via inducing reactive nitrogen
intermediates and host cell apoptosis (reviewed by [30, 31]). However, TNF is a pleiotropic
cytokine and the relative abundance of TNF can determine whether it is protective or deleteri-
ous. TNF has been shown to promote growth of virulent M. tuberculosis in human alveolar
Mø [32]. This agrees with our finding that pre-treatment of bMDM with siRNA against TNF
was deleterious for the intracellular growth of M. bovis strain G18 (Fig 6F), but interestingly
not AF2122/97.
Individually knocking-down the IL10-target genes TNF, NOS2 and IFNG did not promote
M. bovis growth/survival in bMDM. It is possible that the incomplete silencing of these genes
by siRNA failed to reduce their levels to below that inducing a biological effect. Alternatively,
IL10 suppression of these targets may synergistically affect M. bovis survival, which would
require all three genes to be knocked-down simultaneously to observe an effect. However, the
expression of these genes is interlinked, illustrated by the fact that knock-down of each one
altered the expression of at least one of the others (Fig 6), resulting in, at least partial, simulta-
neous knock-down of the genes. Therefore, we conclude that IL10 promotes M. bovis growth/
survival in bMDM by a mechanism other than inhibiting the production of IFNG, TNF and
NO.
Our M. bovis survival studies suggest that IL10 expression during the first 24 h of infection
is important for promoting M. bovis survival in bMDM. Therefore, an alternative mechanism
by which IL10 may promote M. bovis survival in bMDM may relate to the ability of IL10 to
manipulate phagosome maturation. Upon infection M. tuberculosis inhibits the maturation of
the phagosome it resides within, preventing phagosome-lysosome fusion which would result
in mycobacterial degradation [33]. This inhibition requires live M. tuberculosis and IL10 [8].
Treatment of human and bovine Mø with neutralizing anti-IL10 antibody increased the acidi-
fication and maturation of mycobacteria containing phagosomes and reduced intracellular M.
tuberculosis and MAP growth, respectively [8, 9]. Alternatively, intracellular survival of M.
tuberculosis has been associated with the inhibition of Mø autophagy, through the activity of
the protein Enhanced Intracellular Survival (EIS), which depends on the production of IL10
[21]. This protein is also encoded in the M. bovis genome and may therefore function similarly
in bMDM.
In conclusion, we have furthered our understanding of the interaction of two strains of M.
bovis with the infected Mø by investigating the role of IL10 during infection of bMDM. Our
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experiments addressed three main questions. We have identified IFNG as a regulator of IL10
production during M. bovis infection, which could account for the differential expression of
IL10 observed in response to the two strains of M. bovis. Furthermore, we have shown the
IL10 is responsible for the ability of the M. bovis strain G18 to dampen down at least part of
the transcriptional response of bMDM to infection. However, additional, currently unknown,
pathways must be involved in the strain-specific differential transcriptional response of
bMDM. Finally, even though IL10 was differentially expressed in response to the two M. bovis
strains, this cytokine was found to be equally important in promoting M. bovis survival during
the early stage of infection and treatment of cells with siRNA targeting IL10 resulted in a sig-
nificant reduction in intracellular M. bovis numbers. However, the M. bovis strain specific dif-
ferential effects of IL10 on the response of bMDM to infection may have profound effects on
the course of in vivo infection and the progression of bovine TB.
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S1 Fig. Effect of TNF, NOS2 and IFNGR1 knock-down on intracellular M. bovis survival.
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